- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Contact us
- Thank you
XVIVO presents Report on Operations 2022
Invitation to attend XVIVO’s conference call regarding the presentation of the Report on operations 2022. The presentation will be held in English.
Time: Thursday, January 26, 2023 at 2.00 p.m. CET
Please note that the registration process for our quarterly conference calls has changed:
Conference call registration:
Via this link, participants must register to obtain their personal audio conference pin code and details.
Webcast audience URL:
This link gives participants access to the digital live presentation.
Participants from XVIVO:
Christoffer Rosenblad, CEO
Kristoffer Nordström, CFO
The press release for XVIVO’s Report on operations 2022 will be released on January 26, 2023 at 7:30 a.m. CET.
Before the conference call, the presentation will be available at the company web page, https://www.xvivoperfusion.com/corporate/financial-presentations/earnings-calls/
XVIVO Perfusion AB (publ)
For further information, please contact:
Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: firstname.lastname@example.org
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: email@example.com
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.